Charles A. Staley, MD
Holland M. Ware Professor of Surgery and Chief, Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine
Chief of Ambulatory Care Surgery, The Emory Clinic
After receiving his MD with honors from Dartmouth Medical School in 1987, Dr. Charles Staley did his general surgery residency at the University Health Center of Pittsburgh and his surgical oncology fellowship at M.D. Anderson Cancer Center. Throughout his fellowship years he was recognized for his clinical and research interests in the treatment of gastrointestinal and liver cancer, winning such awards as the M.D. Anderson Clinical Fellows Research Award, a University Cancer Foundation Research Grant, a Clinical Fellowship Award from the American Cancer Society, and a Research Project Grant from the Southern Medical Association. Upon completing the fellowship in 1995, Dr. Staley was appointed Holland M. Ware Professor in Surgical Oncology and Chief of the Division of Surgical Oncology of the Department of Surgery, Emory University School of Medicine.
Dr. Staley's clinical specialties include the treatment of stomach, esophageal, colorectal, pancreas, and liver cancer; adrenal masses; and biliary tumors. With research interests encompassing translational research and novel clinical trials in gastrointestinal cancers, he has investigated gene therapy for metastatic colon cancer, radiofrequency ablation with intra-arterial chemotherapy for patients with colorectal liver metastases, and is currently attempting to develop targeted superparamagnetic iron oxide nanoparticles for in vivo imaging and therapy of pancreatic cancer.
Dr. Staley was an Ad Hoc Veterans Administration Oncology Grant Reviewer from 1996-1998, received the Woodruff Fund Clinical Teaching Award in Surgery and the Richard Amerson Resident Teaching Award in 2002, was named one of Emory University's Distinguished Faculty for 2002-2003, sat on the Foregut Staging Committee of the American Joint Committee on Cancer from 2007-2008, and was an Associate Examiner for the American Board of Surgery in 2002 and 2007. He currently holds three positions in the Eastern Cooperative Oncology Group as one of its principle investigators for clinical trials, Co-Chair of the Surgical Committee, and Surgical Chair of the Gastrointestinal Committee. He is also a member of the Society of Surgical Oncology, Society for Surgery of the Alimentary Tract, American Society of Clinical Oncology, Georgia Surgical Society, and a fellow of the American College of Surgeons; leads the Winship Cancer Institute's Gastrointestinal Tumor Study Group; is on the editorial boards of Oncology, Cancer, and Annals of Surgical Oncology and is an Ad Hoc Member of Grant Review Subcommittee H of the National Cancer Institute.
Sound Science: Exploring new treatments for rare cancers